ARDS vs AMGN: Which Stock is Better?

Side-by-side comparison of Aridis Pharmaceuticals Inc and Amgen Inc in 2026

Comparison Updated:

ARDS

Aridis Pharmaceuticals Inc

$0.00

AMGN

Amgen Inc

$331.00

Key Metrics Comparison

MetricARDSAMGNWinner
Market Cap$0.01M$177.92BAMGN
P/E RatioN/A25.57AMGN
EPS (TTM)$N/A$12.92AMGN
Revenue Growth0.0%0.1%AMGN
Gross Margin23.3%70.1%AMGN

Analyze ARDS

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ARDS or AMGN a better investment?

Comparing ARDS and AMGN: Aridis Pharmaceuticals Inc has a market cap of $0.01M while Amgen Inc has $177.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ARDS and AMGN?

ARDS (Aridis Pharmaceuticals Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ARDS or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ARDS or AMGN?

AMGN has higher revenue growth at 0.1% vs 0.0% for ARDS.

Which company is more profitable: ARDS or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.1% compared to 23.3% for ARDS.

Which is the larger company: ARDS or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $177.92B compared to $0.01M for ARDS.

Should I buy ARDS or AMGN in 2026?

Both ARDS and AMGN have investment merit. ARDS trades at $0.00 while AMGN trades at $331.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ARDS and AMGN stock?

Key differences: Market Cap ($0.01M vs $177.92B), P/E Ratio (N/A vs 25.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (23.3% vs 70.1%).

Popular Stock Comparisons